Captopril
Rex N. Brogden, Peter A. Todd, Eugene M. Sorkin · Drugs · 1988
Cited by 318 works. doi:10.2165/00003495-198836050-00003
Authors
References
- Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
- The Effects of Antihypertensive Therapy on the Quality of Life
- A placebo-controlled trial of captopril in refractory chronic congestive heart failure
- Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial Infarction
- TREATMENT OF PATIENTS WITH SYMPTOMLESS LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION
- Effect of vasodilators on survival in chronic congestive heart failure
- Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure.
- The M‐Value, an Index of Blood‐sugar Control in Diabetics
- A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MAN
- Enalapril